Nov 28, 2022, 15:18 PM by

Optibrium appoints Ian Smith as Chief Technology Officer. New role will lead technology development as the Company continues to scale team and global business operations.

Nov 28, 2022, 15:18 PM by

Latest assays in PerkinElmer's growing CGT portfolio

Nov 28, 2022, 15:17 PM by

https://clinioncdn.azureedge.net/wp-content/uploads/2022/11/GDPR_compliance_banner.jpg

Nov 28, 2022, 15:17 PM by

Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers Measuring Brain and Physiological Signals Outside the Lab, Expanding Possibilities for Real-World Clinical Studies

Nov 28, 2022, 15:16 PM by

Nov 25, 2022, 01:00 AM by User Not Found

Bio-IT World | Gone are the days of only measuring single parameters in cell-based experiments. When researchers widen their focus, the end result is an abundant collection of information about the cellular response to perturbations—all nestled within colorful high-content images.

Nov 22, 2022, 01:00 AM by User Not Found

Bio-IT World | Stan Gloss, founder of BioTeam, recently sat down with Mike Tarselli, Chief Scientific Officer at TetraScience, to chat about data for Bio-IT World’s Trends from the Trenches podcast and explore the most recent trends in how the life sciences is talking about and thinking about data.

Nov 18, 2022, 09:42 AM by

Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, today unveiled one of the first and largest post-pandemic, commercial bioaerosol testing facilities. It is designed to evaluate the efficacy of aerosolized products to reduce or eliminate indoor airborne organisms and viral particles in habitable spaces such as transportation, hospitals, and schools. The state-of-the-art lab is at the company’s Eagan, Minnesota site.

Nov 17, 2022, 11:11 AM by

AI could be used to help secure energy supplies by reducing consumption. It could be a fundamental tool for energy independence + energy security.

Nov 17, 2022, 01:00 AM by User Not Found

Bio-IT World | High-resolution mass spectrometry methods are in principle “good enough” to put into clinics everywhere to measure low-abundance environmental chemicals and start cataloguing individual exposures. With a focus on the “exposome"—the measure of all the exposures of an individual in a lifetime and how those exposures relate to health—healthcare professionals are examining clinical exposomics as a foundation for precision medicine.

Nov 16, 2022, 09:30 AM by

The DHP will systematically collect raw digital health data to facilitate collaboration and accelerate the progress of digital health technologies.

Nov 16, 2022, 09:30 AM by

Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the companies' demands with respect to regulatory standards and new services.

Nov 16, 2022, 09:28 AM by

Darling Ingredients’ Health Brand, Rousselot, the global leader in collagen-based solutions, and Gelomics, the world-leading provider of fully integrated 3D cell, organoid and tissue culture technologies, have entered into a cobranding partnership. Rousselot Biomedical will supply Gelomics with its X-Pure GelMA (gelatin methacryloyl), a photo cross-linkable extracellular matrix, for use in Gelomics’ LunaGel™ 3D Tissue Culture System.

Nov 16, 2022, 09:27 AM by

physIQ a leader in continuous remote patient monitoring (cRPM) and data analytics, announced today that OncoBay Clinical, Inc., a leading oncology-focused Contract Research Organization (CRO) has joined the Intrepid™Partner Program. OncoBay will use physIQ’s technology to monitor and evaluate the health and safety of cancer patients and treatment effectiveness in near real-time during the clinical trial process.

Nov 16, 2022, 01:00 AM by User Not Found

Bio-IT World | Scientists at the Montreal Neurological Institute of McGill University (Montreal, Canada) have created an open-source database, called “neuromaps,” housing more than 40 of the uncountably high number of brain maps in existence. The brain maps selected for aggregation were those thought to be most useful to the neuroimaging research community in contextualizing their results against structural and functional phenotypes.

Nov 16, 2022, 01:00 AM by User Not Found

Bio-IT World | Scientists at the Montreal Neurological Institute of McGill University (Montreal, Canada) have created an open-source database, called “neuromaps,” housing more than 40 of the uncountably high number of brain maps in existence. The brain maps selected for aggregation were those thought to be most useful to the neuroimaging research community in contextualizing their results against structural and functional phenotypes.

Nov 15, 2022, 10:36 AM by

The leading seed-stage healthcare venture fund continues to build momentum with entrepreneurs, determined to innovate the global healthcare industry

Nov 15, 2022, 10:35 AM by

Retrospective study demonstrated 56.3% increase in melanoma detection sensitivity through use of contrastive self-supervised learning

Nov 15, 2022, 10:35 AM by

Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has made a number of strategic internal promotions to strengthen its Executive and Management teams. This expansion marks a period of ongoing growth for Domainex, and the newly bolstered teams will be pivotal in driving further development of the company.

Nov 15, 2022, 10:33 AM by

GalNAc modification also contributes to the lower occurrence of off-target tissues for drugs.